Scinovex
article Open Access

Molecular detection of multidrug resistant Mycobacterium Tuberculosis Complex (MTBC) in extra-pulmonary and pulmonary infections in Bauchi LGA, Bauchi State

Journal of Advances in Microbiology Research · 2025 · Vol. 6(2) · pp. 92–95

Abstract

Multidrug Resistant Tuberculosis has lately become a major public health problem that threatens the current achievement in Tuberculosis care and control worldwide, Multidrug Resistant Tuberculosis is a form of tuberculosis that is resistant to two primary drugs (Rifampicin and Isoniazid). This study was designed to identify TB and detect resistance to rifampicin using Genexpert system. MDR-TB was investigated in 250 suspects within the age bracket of 1-90years from 5 clinics in Bauchi. The overall prevalence of tuberculosis/RIF resistant detected was 3.2%, males had the highest prevalence with (2.0%) those at the age bracket of 16-30yrs and 31-45yrs having the high percentages. MDR-TB is not prevalent in Bauchi LGA. Because overall prevalence rate was low. There is need to do more on clinical management to totally eradicate the infection from the area, also, health care providers to encourage early and correct diagnosis, detection and treatments to all TB patients.

Tuberculosis Research and EpidemiologyMycobacterium research and diagnosisDiagnosis and treatment of tuberculosisPulmonary tuberculosisMycobacterium tuberculosis complexMycobacterium tuberculosisTuberculosisMedicineMicrobiologyPulmonary infectionMultiple drug resistanceVirologyBiology

Funding

  • Texas Emerging Technology Fund
  • Tertiary Education Trust Fund
Citations
0
FWCI
0.00
field-weighted impact
References
4
Percentile
22%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Molecular detection of multidrug resistant Mycobacterium Tuberculosis Complex (MTBC) in extra-pulmonary and pulmonary infections in Bauchi LGA, Bauchi State · Scinovex